IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price ...

Idexx Laboratories stock was rising sharply Monday, even as the S&P 500 and major indexes remained in the red. The Dow Jones ...

IDEXX Laboratories, Inc. IDXX posted fourth-quarter 2024 earnings per share (EPS) of $2.62, up 12.9% year over year. The ...

IDEXX (IDXX) stock jumped 12% in early trading Monday after the pet healthcare company issued a Q4 earnings report and 2025 ...

Electric-vehicle maker Tesla and traditional auto manufacturers General Motors and Ford fall but claw back losses with the ...

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & ...

IDEXX Laboratories, Inc. (IDXX) is up by 11.55 percent during Friday morning trading, following the release of its fourth-quarter ...

For the year, the company reported profit of $887.9 million, or $10.67 per share. Revenue was reported as $3.9 billion. Idexx expects full-year earnings to be $11.74 to $12.24 per share, with revenue ...

Idexx forecast revenue between $4.06 billion and $4.17 billion in 2025, in line with analysts' estimates of $4.14 billion. The company also guided for earnings per share in the range of $11.74 and $12 ...

IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...

IDEXX Laboratories, Inc.’s IDXX share price has surged by 11.13%, which has investors questioning if this is right time to ...